PS-341 in Treating Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: bortezomib|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)